As part two of our three-part Virtual Lunch & Learn series on U.S. drug development, this session will focus on the critical role of FDA interactions in a successful pharmaceutical development strategy.

Part 2 will provide a more in-depth understanding of communications with the FDA to facilitate successful product development. We will discuss the different types of interactions and meetings available to sponsors during critical points in the regulatory and strategic product development process. Positive and productive interactions are important to the program; these interactions and associated timelines need to be considered in the overall development program. Interactions help the sponsor to understand the role of the FDA and product-specific offices and, more importantly, provide feedback and guidance on the development program.

Join us for this essential session to learn how to optimize FDA interactions, navigate regulatory touchpoints, and integrate agency feedback into a streamlined development strategy.

Register HERE